Division of Medicinal Chemistry

Division of Medicinal Chemistry
Name	Division of Medicinal Chemistry
Founded	1909
Parent	American Chemical Society
Headquarters	Washington, D.C.
Key people	Dale L. Boger (Past Chair)
Website	https://www.acsmedchem.org/

Division of Medicinal Chemistry. It is a constituent division of the American Chemical Society dedicated to advancing the science of drug discovery and development. The division fosters collaboration among scientists in academia, industry, and government, promoting the application of chemical principles to create therapeutic agents. Its activities encompass a broad range of scientific exchange, professional education, and public advocacy for the field.

History and Mission

The division was originally established in 1909 as a section within the American Chemical Society, reflecting the growing importance of pharmaceutical science following breakthroughs like Paul Ehrlich's work on chemotherapy. Its founding mission was to provide a dedicated forum for chemists engaged in creating medicinal agents, a focus that expanded significantly with the rise of modern pharmacology and the antibiotic era. Throughout the 20th century, it evolved alongside major therapeutic revolutions, including the development of corticosteroids, beta blockers, and protease inhibitors. The core mission remains to advance the chemical sciences as applied to drug discovery, support the professional growth of its members, and disseminate knowledge through its publications and meetings such as the ACS National Meeting.

Organization and Governance

The division operates under the bylaws of the American Chemical Society and is governed by an elected executive committee, which includes a Chair, Chair-Elect, and immediate Past Chair, along with councillors and directors. Key administrative functions are managed by volunteers and supported by staff from the ACS headquarters in Washington, D.C.. It is structured into several committees focusing on areas like program development, awards, and long-range planning, ensuring alignment with the strategic goals of the broader ACS. The division also collaborates closely with other ACS divisions such as the Division of Biological Chemistry and international bodies like the European Federation for Medicinal Chemistry.

Scientific Scope and Research Areas

The scientific purview encompasses the entire continuum of drug discovery, from initial target identification to clinical candidate selection. Core research areas include rational drug design, combinatorial chemistry, pharmacokinetics, and the study of structure-activity relationships. Significant emphasis is placed on emerging fields such as chemical biology, fragment-based drug discovery, and the application of artificial intelligence in hit identification. The division actively promotes research at the interface with biochemistry and molecular biology, addressing challenges in areas like oncology, infectious diseases, and neuroscience, often highlighted in symposia at the Spring ACS National Meeting.

Educational and Professional Activities

A primary function is to provide continuing education and career development for its global membership. This is achieved through specialized workshops, webinars, and short courses offered in conjunction with the ACS National Meeting and other venues like the MEDI Division symposium. The division supports early-career scientists via travel awards to major conferences, including the Fall ACS National Meeting, and mentorship programs connecting students with researchers from Pfizer or Merck & Co.. It also develops educational resources for undergraduate and graduate curricula in medicinal chemistry, fostering the next generation of scientists for careers in the pharmaceutical industry and academia.

Awards and Recognition

The division administers several prestigious awards to honor excellence in the field. The highest honor is the E.B. Hershberg Award for important discoveries in medicinally active substances, while the David W. Robertson Award recognizes outstanding contributions to the education of medicinal chemists. Other significant accolades include the ACS Award for Creative Work in Synthetic Organic Chemistry and the division's own Young Investigator's Symposium Award, which showcases promising early-career talent. Recipients of these awards are often leading figures from institutions like Scripps Research or GlaxoSmithKline and are celebrated during award symposia at the ACS National Meeting.

Publications and Conferences

The division is a primary sponsor of the Journal of Medicinal Chemistry, a leading publication co-published with the American Chemical Society. It also contributes to content for ACS Medicinal Chemistry Letters and organizes seminal scientific conferences. Its flagship programming occurs within the technical divisions of the biannual ACS National Meeting, featuring hundreds of presentations. The division frequently co-sponsors specialized international meetings with organizations like the International Society for Medicinal Chemistry and hosts the annual MEDI Division poster session, a key networking event for researchers from Novartis, AstraZeneca, and universities worldwide.

Notable Members and Leadership

Throughout its history, the division has been led and influenced by eminent scientists who have shaped modern drug discovery. Past chairs include renowned figures like Dale L. Boger of Scripps Research and Philip S. Portoghese of the University of Minnesota. Other distinguished members have been recipients of the Nobel Prize in Chemistry, such as Robert Lefkowitz, and leaders of major research initiatives at National Institutes of Health. The division's councilors and committee members often hold prominent positions in the pharmaceutical industry, at regulatory agencies like the FDA, and within prestigious academic departments across the United States and Europe.

Category:American Chemical Society divisions Category:Medicinal chemistry organizations Category:Scientific organizations established in 1909